CD4 and inflammation: We have previously shown that the systemic administration of S1P to BALB/c mice triggers an increase in airway reactivity and pulmonary inflammation that is dependent upon a Th2 response as confirmed by a specific adoptive transfer experiment using CD4+ T cells harvested from S1P-treated BALB/c mice (17).